Optogenetics can control specific molecular events in living systems, but the penetration depth of 15 light is typically limited at hundreds of micrometers. Focused ultrasound (FUS), on the other 16 hand, can deliver energy safely and noninvasively into tissues at depths of centimeters. Here we 17 have developed an acoustogenetic approach using short-pulsed FUS to remotely and directly 18 control the genetics and cellular functions of engineered mammalian cells for therapeutic 19 purposes. We applied this acoustogenetic approach to control chimeric antigen receptor (CAR) T 20 cells with high spatiotemporal precision, aiming to mitigate the potentially lethal "on-target off-21 tumor" effects of CAR T cell therapy. We first verified the controllability of our acoustogenetic 22 CAR T cells in recognizing and killing tumor cells in vitro, and then applied this approach in 23 vivo to suppress tumor growth of both lymphoma and prostate cancers. The results indicate that 24 FUS-based acoustogenetics can allow the noninvasive and remote activation, without any 25 exogenous cofactor, of different types of CAR T cells for cancer therapeutics.
We transduced Nalm-6 cells with a lentiviral dual-luciferase reporter containing inducible Fluc 138 and constitutive Rluc (Hsp-Fluc-PGK-Rluc-mCherry; Rluc, Renilla luciferase; Fig. 3b ) and 139 embedded them in a tofu phantom approximately 7 mm deep from the top surface ( Fig. 3c and   140 Methods). We then focused the ultrasound on the embedded cells by changing the focal distance 141 in the z direction. Three pulses of 5-min FUS stimulations caused a significant induction of gene 142 expression as quantified by the Fluc/Rluc ratio of the cells assayed 8 hr later (Fig. 3d, Methods) . 143 The induction level is comparable to that of the positive control using thermal cycler with the 144 same heating pattern ( Fig. 3d ), suggesting the acoustogenetic approach can remotely control 145 gene activation in engineered cells with high efficiency.
146 147 We then used MRI-guided FUS to control local temperature in vivo in mouse (Fig. 3 , e and f and 148 Movie S2) and tested the FUS-induced gene activation using Nalm-6 cells with the dual-149 luciferase reporter in vivo. Significant gene induction was observed in the implanted cells with 150 only two pulses of 5-min FUS stimulation (FUS+, after), in comparison to the basal level (FUS+, 151 before) and the control groups (FUS-, before and after) ( Fig. 3, g and h) . 153 We next tested the tumor cytotoxicity of the FUS-inducible CAR T cells in vivo. We 154 subcutaneously injected Nalm-6 cells (Fluc+) on both hindlimbs of NSG mice to generate 155 matched bilateral tumors (Fig. 4a ). Four days later, engineered CD19CAR T cells were 156 subcutaneously injected at both tumor sites locally, followed by three pulses of 5-min FUS local site had negligible off-site effects in attacking the distal tissues on the contralateral 161 hindlimb expressing the same antigens. We further performed a control experiment subjecting We anticipate that comparable therapeutic outcomes can be achieved in a reversible heat- In vitro heat shock 293 For Fig. 1c and Movie S1, cells seeded in a glass bottom dish were heated at 43°C for 15 min 294 using a heating stage (Instec) integrated with a Nikon Eclipse Ti inverted microscope. Images washed and resuspended in cell culture medium at a concentration of 2 x 10 6 cells/mL, aliquoted 298 into 8-strip PCR tubes with 50 µL/tube, and heat shocked at 43°C using a thermal cycler (Bio-299 Rad, 1851148) with various patterns as indicated (Table S2 ). Cells were returned to standard 300 culture condition after HS. The gene induction levels were quantified by flow cytometry 12 hr 301 after HS in Fig. 1, f and g, and fig. S3 , d and e.
152

FUS-inducible tumor cytotoxicity of the engineered CAR T cells in vivo
303
Engineered cells 304 The engineered cells (excluding primary human T cells) used in this work are listed in Table S3 . 305 Lentiviruses were used to deliver engineered genes into the cells. Fluorescence-activated cell quantified using the CAR antibody as described above.
344
Luciferase-based cytotoxicity assay 346 A constant number of 5 x 10 4 Fluc+ Nalm-6 cells were mixed with engineered primary human T 347 cells with or without HS (pre-washed and resuspended with complete RPMI without IL-2) at 348 effector-to-target (E:T) ratios of 1:50, 1:20, 1:10, 1:5, 1:1, 5:1 or no T cells ("target cell only"). complete RPMI without IL-2) were added 6 hr later at E:T ratios of 1:10, 1:5, 1:1, 5:1, 10:1, 359 20:1. The luminescence was quantified 24 hr after co-culture as described above. Animal experiments were performed following Protocol S15285 approved by UCSD IACUC.
381
NSG mice (6-8 weeks old) were purchased from Jackson Laboratory (JAX) and shaved prior to 382 FUS stimulation. Anesthesia was induced using 2% isoflurane-oxygen mixture and maintained 383 with 1.5% isoflurane-oxygen mixture during FUS stimulation. The mouse was laid on its side on 384 an MR bed containing an agarose gel pad and a surface coil. A pressure pad was placed under 385 the mouse to monitor its respiration rate, and a rectal thermal probe was used to provide 386 feedback for the delivering of warm air into the bore to maintain the mouse's core temperature at 387 approximately 37°C. The ultrasound transducer was positioned right above the targeted region on the mouse's hindlimb. Thin layers of SCAN ultrasound gel (Parker labs) were applied at the 389 skin-transducer and skin-bed interfaces.
391
The ThermoGuide software regulates the temperature in a 3 x 3 pixel square (3 -4 mm 2 ) 392 centered at the ultrasound focus (Fig. 3e) . A PID controller is used to maintain the average 393 temperature of the target square at 6°C above reference by controlling the output power of the 394 FUS generator, with the reference temperature being 37°C as measured by the rectal thermal 395 probe. As such, the MRI-guided FUS enabled temperature elevation to 43°C locally at the focal 396 area in the hindlimb of an anesthetized mouse. 399 For FUS stimulation on cells in the tofu phantom, Nalm-6 cells were lentivirally transduced with 400 the dual-luciferase reporter (Fig. 3b , Hsp-Fluc-PGK-Rluc-mCherry) and FACS-sorted. The cells 401 were resuspended in culture medium and mixed with matrigel (Corning, 354262) at 1:1 volume 402 ratio on ice. Extra-firm tofu was cut into a 15-mm thick pad, and an 8-mm deep hole of 8-mm 403 diameter was drilled from the top. A microcentrifuge tube of 7.5-mm diameter (Fisherbrand, 05-404 408-120) was cut to 8-mm long by removing the lid and the conical bottom, and was inserted 405 into the hole in the tofu phantom. Cell-matrigel mixture of 150 µL was added into the hole (~3 406 mm thick) and allowed to gel at room temperature. The rest of the hole and the gap between the 407 tube and the tofu phantom were filled up with matrigel. After gelation, the assembly was 408 inverted and positioned onto the MR bed containing the surface coil. The ultrasound transducer 409 was positioned above the tofu phantom with its center aligned with that of the tube. Thin layers of ultrasound gel were applied at the tofu-transducer and tofu-bed interfaces. A thermal probe 411 was inserted into the distal end of the tofu phantom to provide reference temperature readings. 412 413 MR images of the assembly were acquired and transferred to ThermoGuide to calculate the 414 theoretical ultrasound focal position. Test FUS shots were delivered to determine the actual focal 415 position. Steering was applied to focus the ultrasound at the region immediately above the cells.
FUS stimulation in tofu phantom
416
Three pulses of 5-min FUS stimulations at 43°C were applied. The cell-matrigel mixture was 417 then recovered from the tube, placed in cell culture medium, and returned to a standard 37°C cell 418 culture incubator. After 6 hr, the culture was centrifuged to remove the supernatant, and the cell- Images were analyzed using Living Image software (PerkinElmer), and the integrated Fluc 432 luminescence intensities within regions of interest were quantified to represent tumor sizes. 435 NSG mice (male, 6-8 weeks old) were subcutaneously injected with 2 x 10 6 dual-luciferase 436 reporter Nalm-6 cells at the hindlimb. One week later, the experimental mice received two pulses 437 of 5-min FUS stimulation at 43°C targeted at the implanted cells, while the control mice 438 remained unstimulated. The in vivo Fluc and Rluc luminescence was quantified 4 hr before and 439 12 hr after FUS stimulation, as described above.
433
FUS-inducible gene activation in vivo
441
In vivo tumor cytotoxicity of FUS-inducible CAR T cells. 442 NSG mice (male, 6-8 weeks old) were subcutaneously injected with 2 x 10 5 Fluc+ Nalm-6 cells 443 (or 2 x 10 5 PSMA+ Fluc+ PC3 cells, for PC3 tumors) on both hindlimbs to generate matched 444 bilateral tumors. Four days later (or five days later, for PC3 tumors), 1 x 10 6 inducible primary 445 human CAR T cells prepared as described above were injected subcutaneously and locally at 446 tumor regions. Within 4 -8 hr after T cell injection, three pulses of 5-min FUS stimulation 447 targeted at 43°C were applied on the left tumor region as described above, while the tumor on the 448 right hindlimb received no FUS stimulation to serve as the control. Tumor aggressiveness was 449 monitored by BLI twice a week as described above until euthanasia criteria were met.
451
Quantification of mRNA expression in tumor tissue.
452
PC3 tumors (Fig. 4, d and e ) were harvested 22 days after tumor implantation (17 days after T 453 cell injection and FUS stimulation). The tumors were disrupted and homogenized, and the same 454 amount of lysate from each tumor was used to extract total RNA with the RNeasy Mini Kit 455 (Qiagen, 74104) followed by reverse transcription using the same amount of template RNA. 456 Quantitative PCR (qPCR) was performed using iTaq TM Universal SYBRRTM Green Supermix 457 (Bio-Rad, 1725121), the same amount of template cDNA, and the specific primers described 458 below. The mRNA levels were normalized to b-actin. Statistics. 476 One-way ANOVA followed by Tukey's multiple comparisons test is used for Figs. 1, f and g, and 
